Crescent Biopharma, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $8.5M | $28.2M |
| FY2012 | — | $12.5M | $17.4M |
| FY2013 | — | $2.9M | $2.3M |
| FY2014 | — | $50.8M | $55.2M |
| FY2015 | — | $40.5M | $46.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $8.5M | $28.2M |
| FY2012 | — | $12.5M | $17.4M |
| FY2013 | — | $2.9M | $2.3M |
| FY2014 | — | $50.8M | $55.2M |
| FY2015 | — | $40.5M | $46.8M |